L3VLUP
ProSign in

TECH · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

TECHAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • TECH
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterTECHAMGN
Q3 202014 holders, $1.2bn16 holders, $16.3bn
Q4 202010 holders, $1.2bn19 holders, $14.0bn
Q1 202111 holders, $1.5bn16 holders, $14.5bn
Q2 20216 holders, $1.4bn23 holders, $13.8bn
Q3 20218 holders, $1.5bn24 holders, $11.6bn
Q4 20219 holders, $1.9bn21 holders, $10.4bn
Q1 20227 holders, $1.3bn23 holders, $9.9bn
Q2 202213 holders, $1.3bn28 holders, $9.7bn
Q3 202213 holders, $1.0bn21 holders, $7.9bn
Q4 20229 holders, $954m24 holders, $9.3bn
Q1 202315 holders, $896m22 holders, $8.4bn
Q2 202310 holders, $1.2bn26 holders, $7.4bn
Q3 202310 holders, $960m26 holders, $8.7bn
Q4 202310 holders, $1.2bn24 holders, $8.4bn
Q1 20248 holders, $1.2bn25 holders, $6.7bn
Q2 20247 holders, $1.4bn20 holders, $8.0bn
Q3 202410 holders, $2.1bn21 holders, $8.8bn
Q4 20248 holders, $1.7bn20 holders, $8.2bn
Q1 20258 holders, $1.2bn25 holders, $12.0bn
Q2 20258 holders, $860m20 holders, $10.2bn
Q3 202514 holders, $1.4bn17 holders, $10.4bn
Q4 202513 holders, $1.7bn19 holders, $18.0bn
Q1 202610 holders, $1.6bn15 holders, $21.4bn
Q2 202621 holders, $2.6bn23 holders, $24.9bn
TECH

Bio-techne Corp

Holders
10
Reported value
$2.1bn
Buyers
4
Sellers
6

Breadth -2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
21
Reported value
$8.8bn
Buyers
16
Sellers
5

Breadth +11 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q3 2024

Among the 26 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only TECH (5)

MFS Investment Management, Millennium Management LLC, Point72 Asset Management LP, Polen Capital Management LLC, Wellington Management Group LLP

Only AMGN (16)

AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Farallon Capital Management LLC, Fidelity (FMR LLC), Man Group PLC, Two Sigma Advisers LP, Two Sigma Investments LP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →